Ebcay, Rinalyn M.
HRN: 23-11-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2023
CEFUROXIME 1.5GM (VIAL)
05/25/2023
05/25/2023
IV
1.5g
Now ANST
Minimal Infiltrates On Right Lower Lung Field
Waiting Final Action
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes